Immediate Impact
57 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Contemporary radiotherapy: present and future
2021 Standout
Works of Anna Russo being referenced
CAPTEM or FOLFIRI as second-line therapy in neuroendocrine carcinomas and exploratory analysis of predictive role of PET imaging and biological markers (SENECA study)
2018
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anna Russo | 542 | 266 | 465 | 73 | 1.1k | |
| Belinda A. Campbell | 398 | 198 | 502 | 71 | 1.1k | |
| Chul Yong Kim | 490 | 297 | 323 | 92 | 1.2k | |
| Tan Dat Nguyen | 278 | 348 | 197 | 40 | 1.2k | |
| Rahul R. Parikh | 336 | 366 | 304 | 75 | 1.0k | |
| K.A. Dinshaw | 399 | 171 | 370 | 46 | 930 | |
| Michael C. Stauder | 353 | 346 | 233 | 71 | 1.2k | |
| Marie‐Luise Sautter‐Bihl | 324 | 279 | 351 | 44 | 1.2k | |
| Anthony J. Piro | 397 | 329 | 212 | 41 | 1.1k | |
| Christian Baues | 446 | 377 | 393 | 94 | 1.0k | |
| J. Bullimore | 260 | 318 | 325 | 42 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...